China's Top 20 Medical Device Companies of 2023 Announced at Mins Congress

On June 25, in Huzhou, Zhejiang, at the 2024 MISSION Conference, 2023Top 100 List of Chinese Chemical Pharmaceutical Enterprises, Top 100 List of Chinese Traditional Medicine Enterprises in 2023,CXOTop 20 Enterprises Ranking, Top 20 China Medical Device (including IVD) Enterprises Ranking 2023, Top 20 China Biomedical (including blood products, vaccines, insulin, etc.) Enterprises Ranking 2023 – The five major rankings have been officially released, with a total of 260 enterprises listed.See the full list at the end of the article.）。

01

China's Medical Device Companies in 2023, etc.

Top 3TOP20List Released

Top 20 List of Chinese CXO (including CDMO) Companies in 2023 Revealed: WuXi AppTec, Tigermed,PharmaronRanked in the top 3.

In the TOP20 ranking of China's CXO companies in 2022 and 2021, the top three companies are WuXi AppTec, WuXi Biologics, and Tigermed.

Top 20 Rankings of Chinese Medical Device (Including IVD) Companies in 2023 Revealed: Mindray Medical, United Imaging Healthcare, and Weigao Group Hold Top Three Spots, Maintaining Their Positions from 2022 and 2021.

In the TOP20 Ranking of China's Biopharmaceutical Enterprises (Including Blood Products, Vaccines, Insulin, etc.) in 2023, BeiGene, Zhifei Biological, and Changchun High-Tech ranked top three, consistent with their rankings in 2022 and 2021.

As for the companies ranked slightly lower on the list, the rankings of companies in the three sub-lists have changed significantly, especially in the China CXOTOP20 list, where the iteration of rankings is obvious—some companies have dropped out of the TOP20. In contrast, the performance of companies in the China Biopharmaceuticals (including blood products, vaccines, insulin, etc.) TOP20 list has been relatively stable.

Beyond the fact that the strong remain strong, even the leading companies in each细分赛道 exhibit varying performances from year to year.

"Top 100 Chinese Chemical Pharmaceutical Enterprises in 2023" Announced

TOP10 pharmaceutical companies have slight changes in ranking

CPhI China learned on the spot that the top 10 enterprises entering the "Top 100 Chinese Chemical Pharmaceutical Enterprises in 2023" are:Hengrui Medicine, China Biologic Products, Shanghai Pharmaceutical Group, CSPC Pharmaceutical Group, Qilu Pharmaceutical, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical, Hansoh Pharma,Healthcare Pharmaceutical, Huadong Medicine.

Note: Taken by Saibailan on site

Unlike the stable top ten pattern from 2019 to 2022 for four consecutive years, the TOP10 pattern of chemical pharmaceutical enterprises in 2023 has seen new changes.

On one hand, the top six companies remain in their positions; on the other hand, Sichuan Kelun Pharmaceutical's ranking rises by one place, moving from 8th to 7th. Jiangsu Hansoh Pharmaceutical participates in the "2023 Top 100 Chinese Chemical Pharmaceutical Enterprises Ranking" as Hansoh Pharma, dropping one place to become 8th. The rankings of the 9th and 10th companies, Healthoo and Huadong Medicine, remain unchanged.

According to the梳理 by Saibailun, the top 10 enterprises in the TOP100 rankings of Chinese chemical pharmaceutical companies for four consecutive years from 2019 to 2022 are: Hengrui Medicine, China Biologic Products, Shanghai Pharmaceutical Group, CSPC, Qilu Pharmaceutical, Shanghai Fosun Pharmaceutical, Jiangsu Hansoh Pharma, Sichuan Kelun Pharmaceutical, Joincare Pharmaceutical, and Huadong Medicine.

"Top 100 Chinese Herbal Medicine Enterprises in China 2023 Ranking" Announced

TOP10 Pharmaceutical Companies Show Significant Ranking Changes

The top 10 enterprises in the "2023 China Top 100 Traditional Chinese Medicine Enterprises Ranking" are:Guangzhou Pharmaceutical Group, Huarun Sanjiu, China Traditional Chinese Medicine, Buchang Pharmaceutical, Yunnan Baiyao, Beijing Tong Ren Tang, Shijiazhuang Yiling Pharmaceutical, Jichuan Pharmaceutical, Tasly Pharmaceutical Group, Tianjin Pharmaceutical Group.

The traditional Chinese medicine sector of Tianjin Pharmaceutical Group includes Darrentang, Liuzhongyao, Longshunrong, Leren Tang, and Jingwanhong.

Compared with the "TOP 100 Chinese Medicine Enterprises in China 2022 Ranking," in the 2023 ranking, the top four Chinese medicine enterprises remain unchanged. Yunnan Baiyao, ranked 5th, moved up one place. Beijing Tong Ren Tang, ranked 6th, moved up two places. Shijiazhuang Yiling Pharmaceutical, ranked 7th, dropped two places. Jichuan Pharmaceutical, ranked 8th, dropped one place. Tianjin Tasly Pharmaceutical Group, ranked 9th, and Tianjin Pharmaceutical Group, ranked 10th, remained in the same positions as in 2022.

In addition, Cephylline has compiled the top 10 companies in the TOP100 ranking of Chinese herbal medicine enterprises in China since 2019. Overall, the rankings of the TOP10 companies have been continuously changing.Compared with chemical drug companies, the competition for rankings among traditional Chinese medicine companies is more intense.

Specifically:

Top 10 Enterprises in the "2021 Top 100 Chinese Medicine Enterprises in China" Ranking: Guangzhou Pharmaceutical Holdings, China Traditional Chinese Medicine, Huarun Sanjiu, Buchang Pharmaceutical, Yunnan Baiyao, Shijiazhuang Yiling Pharmaceutical, Beijing Tong Ren Tang, Jichuan Pharmaceutical, Tasly Pharmaceutical Group, Zhejiang Conba.

Top 10 enterprises in the "2020 China Top 100 Traditional Chinese Medicine Enterprises Ranking": Guangzhou Pharmaceutical Holdings, Buchang Pharmaceutical, Huarun Sanjiu, China National Pharmaceutical Group, Yunnan Baiyao, Tasly, Yiling Pharmaceutical, Beijing Tong Ren Tang, Jichuan Pharmaceutical, and Conba.

Top 10 enterprises in the "2019 Top 100 Chinese Medicine Enterprises in China Ranking": Guangzhou Pharmaceutical Group, Buchang Pharmaceutical, China Resources Sanjiu, Tasly, China Traditional Chinese Medicine, Yunnan Baiyao, Beijing Tong Ren Tang, Jichuan Pharmaceutical, Conba, and Yiling Pharmaceutical.

Attachment: Top 100 Chinese Chemical Pharmaceutical Enterprises in 2023 and 5 Other Rankings (Organized by CPhI China at the 2024 MISSION Conference)

- END -

Pharmaceutical Representatives Communication and Mutual Assistance Group Scan the QR code below to join	Silver Economy Market Opportunities Communication Group Scan the QR code below to join